Crescent Biopharma, Inc., a Cayman Islands company incorporated in Delaware in 2003, is a late-stage clinical biotechnology company focused on improving the lives of patients with cancer and inflammatory diseases by inhibiting carbohydrate interactions that occur on the cell surface. The company is developing a proprietary pipeline of sugar mimics, small molecules that mimic the structure of carbohydrates and are involved in important biological processes that inhibit carbohydrate disease-related functions. 

CBIO

CBIO Profile